2007 Imprimatur Capital Limited 1 Private & Confidential “Investing in Knowledge” October 2007.
-
Upload
wilfrid-osborne -
Category
Documents
-
view
221 -
download
4
Transcript of 2007 Imprimatur Capital Limited 1 Private & Confidential “Investing in Knowledge” October 2007.
2007 Imprimatur Capital Limitedwww.impcap.com 1
Private & Confidential
“Investing in Knowledge”
October 2007
Private & Confidential 2007 Imprimatur Capital Limited
www.impcap.com 2
Imprimatur Capital – Who We Are
Imprimatur is an international, operational, principal investment business focussing on the emerging asset class of IP Equity and founded on long-term relationships with key universities
and research institutes worldwide.
Private & Confidential 2007 Imprimatur Capital Limited
www.impcap.com 3
The Business Model
• Long-term partnerships with top universities and research institutes;
• Disciplined market driven technology focus;
• International perspective and resources;
• A recognition that capital, in and of itself, is not a determinant of success;
• Strong operational team and Industry / Scientific Advisory Group who work closely with our partners and portfolio companies;
• Targeting a broad range of key technologies;
• A dynamic network used to identify technology and market gaps;
• Working with key regional and national stakeholders for mutual benefit.
Private & Confidential 2007 Imprimatur Capital Limited
www.impcap.com 4
Imprimatur’s Position in the Commercialisation Cycle
3 mos 6 mos 9 mos 1 yr
IP/Prototype?
Applications vs. Markets
No: Customers Revenues
Management Plans
“IC First Look Option Period”
University TTO Process:
IP Protection; Consider Applications; Opportunity Summary; Obtain Academic Buy-In; Complete
Internal Admin; Prepare Outline Plan for Investors.
TTO Ready to Involve External Partners
Imprimatur Capital Angel/Seed Investors Series “A” VC
Lead/Co-Investor Still Required
Finished Products
Identified Markets
Customers
Growing Revenues
Management Team
Private & Confidential 2007 Imprimatur Capital Limited
www.impcap.com 5
Investment Process
PipelineTechnical Analysis
Transaction Management
Portfolio Management
Revenue Recognition
External Advisors
Investment Committee
Capital Markets
Transaction Management
Human Capital
In-House Team
Tech Transfer
Private & Confidential 2007 Imprimatur Capital Limited
www.impcap.com 6 2007 Imprimatur Capital Limited
www.impcap.com 6Private & Confidential
International Network
- partnerships in development
- existing partnerships
- office locations
- proposed office locations
Private & Confidential 2007 Imprimatur Capital Limited
www.impcap.com 7 2007 Imprimatur Capital Limited
www.impcap.com 7Private & Confidential
International Network
- partnerships in development
- existing partnerships
- office locations
- proposed office locations
Private & Confidential 2007 Imprimatur Capital Limited
www.impcap.com 8 2007 Imprimatur Capital Limited
www.impcap.com 8Private & Confidential
International Network
- partnerships in development
- existing partnerships
- office locations
- proposed office locations
Private & Confidential 2007 Imprimatur Capital Limited
www.impcap.com 9 2007 Imprimatur Capital Limited
www.impcap.com 9Private & Confidential
International NetworkRussian Team
Technical & Market Assessment Experts
Ben Ferrari –Managing Director
Steve Hughes – Associate Director Technology Transfer
Juan Matthews - Associate Director Technology Transfer
Tanya Mackenzie - Associate
Toby Moore –Director Baltic Seas
Janis Janevics – Associate Director
Gala Shaposhnikova – Consultant Tomsk
Alex Kvashnin – Consultant Novosibirsk
Private & Confidential 2007 Imprimatur Capital Limited
www.impcap.com 10
Focus on High Growth Technology Sectors
• Information and Communication Technology;
• Nanotechnology/MEMs;
• New Energy;
• Materials Science;
• Optics and Photonics;
• Security and Defence;
• Biosciences.
Private & Confidential 2007 Imprimatur Capital Limited
www.impcap.com 11
The “House” Views
• Imprimatur researches investment themes within target sectors to identify technology gaps;
• Input from Imprimatur’s prestigious Industry and Scientific Advisory Groups;
• Proprietary “House View” on each sector;
• Imprimatur targets IP from across its university network;
• Creating valuable solutions, fulfilling real commercial needs.
Private & Confidential 2007 Imprimatur Capital Limited
www.impcap.com 12
Assessment Outcome
Innovation
Proof of concept
Licensing
Start-up
Not for us
Assessment
Proof of concept: Imprimatur funds proof of concepts when we believe thereis potential but there are one or more technical milestones to be achieved
Licensing: Imprimatur has created specialized IP licensing vehicles in areas such as Security (OrbisIP) and Communications Technologies (ICIPR).
Private & Confidential 2007 Imprimatur Capital Limited
www.impcap.com 13
Broad criteria considered for a start-up
• Inventor(s) enthusiastic about commercialization• Degree of novelty • Protectable intellectual property• Technical feasibility • Visible route-to-market • Growth potential• Size of the potential market • Potential for attracting follow-on investors• Imprimatur’s ability to add value beyond “just money”
Private & Confidential 2007 Imprimatur Capital Limited
www.impcap.com 14
Current Portfolio
INFORMATION AND COMMUNICATION
TECHNOLOGY
• Superstructure (unstructured data mining tool)
• Mobile Acuity (mobile image recognition tech)
• Layered Sound (sound tech)
• ICIPR (communications)
• Fubat (mobile gaming)
• Clusterpoint (mobile search tech)
• Leximancer (unstructured data analysis)
• Manbujia (wireless infrastructure and services)
NANOTECHNOLOGY /MEMs
• Quantum Precision (nano-measurement devices)
NEW ENERGY
• SAFC (solid oxide fuel cell)
• Quicksilver (biodiesel production tech)
BIOSCIENCES
• Vittamed (non-invasive medical devices)
• Colisa (cuffless blood pressure monitor)
• BigDNA (phage vaccine platform)
SECURITY AND DEFENCE
• InfoGov (compliance, information security)
• OrbisIP (security)
The companies in our Current Portfolio are actively supported by the BDMs, Regional
Managers and by our Scientific and Industry Advisors
Private & Confidential 2007 Imprimatur Capital Limited
www.impcap.com 15
Current Activity – Pipeline
Strong pipeline across all territories and sectors including:• Functional foods – anti-obesity (UK & Spain)
• Biodiesel production (Ukraine)
• Point of care diagnostics (Hong Kong)
• Blood glucose measurement (UK)
• Quantum cryptography (Australia)
• Third generation solar power (Sweden)
• Wireless security (Russia)
• Nano-technology (Singapore & Ukraine)
• Mobile Gaming (UK)
Private & Confidential 2007 Imprimatur Capital Limited
www.impcap.com 16
Case Study 1
2003 2004 2005 2006 2007
POC development
BusinessPlan
Completed
Mobile Acuity
Engagement of VC community
Competingoffers frominvestors
Imprimaturinvestmentcompleted
Due Diligence andsupport with
business plan development
First significant
sale
FirstProduct
ready
Foundersdevelopconcept
Private & Confidential 2007 Imprimatur Capital Limited
www.impcap.com 17
First application is in mobile marketing
MOBILEVISUAL RECOGNITION
TECHNOLOGY AND PLATFORM
Private & Confidential 2007 Imprimatur Capital Limited
www.impcap.com 19
Why did we invest in Mobile Acuity?• Inventor(s) enthusiastic about commercialization
• Current managing director was the inventor• Degree of novelty
• High in the application domain and overall vision• Protectable intellectual property
• A patent licensed from the university• Technical feasibility
• A demo was available at the time of investment• Route-to-market feasibility
• A ideal application in the mobile market was identified and pursued successfully
• Growth potential• Huge, as it is starting from zero
• Size of the potential market • Every mobile phone use is a potential customer
• Potential for attracting follow-on investors• The mobile platform and application space is very hot
Private & Confidential 2007 Imprimatur Capital Limited
www.impcap.com 20
Russian Investment
• Early stage start-up working in the area of mobile/compact power generation systems based on novel ferroelectric materials.
• Based in Novosibirsk – strong reputation of team and supporting institutes.
• Imprimatur providing ‘matched’ investment with FASIE funding.
• Patents in place PCT – scope for further IP.
Private & Confidential 2007 Imprimatur Capital Limited
www.impcap.com 21
Conclusion
• Growing international momentum in commercialization of University IP
• Imprimatur leading the development in this field • Imprimatur’s core model based around:
– Working with key Stakeholders– Alignment of interests with institutes and academic
founders – Extensive scientific, geographic and commercial
network – Provision of essential support services as well as cash